
Opinion|Videos|July 2, 2024
RSV Vaccine Efficacy in Pregnancy
Author(s)Carrie Koenigsfeld, PharmD, FAPhA
Carrie Koenigsfeld, PharmD, FAPhA, highlights the main findings from the MATISSE trial, which evaluated the safety and efficacy of a non-adjuvanted RSV vaccine administered to pregnant women, presenting data that suggests the vaccine's effectiveness in preventing severe RSV in infants and discussing the observed adverse events in both mothers and infants.
Advertisement
Episodes in this series

- What were the key results from the
MATISSE trial regarding the safety and efficacy of the non-adjuvanted vaccine in pregnant women?- Efficacy in preventing severe RSV in infants
- Adverse effects in maternal and infant subjects
- Trial limitations: no high-risk pregnancies
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Oral Semaglutide Approved to Reduce the Risk of Cardiovascular Events
2
Q&A: Pharmacists’ Role in Counseling Patients on Shingles Vaccination, Long-Term Health
3
Research Finds No Clinically Important Increase in Autism, ADHD Following Prenatal Paracetamol Use
4
Address Health Disparities Through Pharmacist-Led Initiatives in Underserved Communities
5













































































































































































































